We assessed a cohort of people living with human immunodeficiency virus (PLWH)(n= 110)
and HIV negative controls (n= 64) after 1, 2 or 3 SARS-CoV-2 vaccine doses. At all …

Introduction This study sought to explore the immunogenicity of a booster dose of an
inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine in …

Despite the development of vaccines, which protect healthy people from severe and life-
threatening Covid-19, the immunological responses of people with secondary …

Few studies have comprehensively compared severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccine-induced and hybrid B-and T-cell responses in people …

People living with HIV (PLWH) may be at risk for poor immunogenicity to certain vaccines,
including the ability to develop immunological memory. Here, we assessed T-cell …

In some instances, unsuppressed HIV has been associated with severe COVID-19 disease,
but the mechanisms underpinning this susceptibility are still unclear. Here, we assessed the …

Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 …

Despite vaccination and antiviral therapies, immunocompromised individuals are at risk for
prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, but the …

Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a …

There is an urgent need to understand the nature of immune responses against SARS-CoV-
2, to inform risk-mitigation strategies for people living with HIV (PLWH). Here we show that …